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The aryl hydrocarbon receptor (AhR) is a bHLH protein and member of a relatively homologous, but functionally diverse, family of proteins containing one or more PAS (Per-Arnt-Sim) domains. This family contains the AhR's heterodimerization partner the aryl hydrocarbon receptor nuclear translocator (Arnt) as well as hypoxia inducible factor-1α (HIF-1α) and principal components of circadian rhythm regulators, Clock and BMAL1. In addition to being a highly-conserved, developmentally-regulated, and ligand-activated transcription factor (Hahn, 2002; Williamson et al., 2005) , the AhR is also the protein mediator for the action of several organic toxicants, typified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Altered immuno-hematopoietic parameters, including both humoral and cellular, are among the most consistently observed toxicities following activation of the AhR by xenobiotic agonists such as TCDD. A hallmark of AhR-mediated toxicity is a persistent atrophy/aplasia of the thymus. Although this is may be partly due to effects on thymocyte proliferation (Laiosa et al., 2003) , other data suggest that other upstream cellular targets exist that may contribute to this effect. In particular, the sensitivity of Lin -Sca-1 + cKit + (LSK) bone marrow cells, a population highly enriched for multipotent hematopoietic stem cells (HSC), to TCDD was demonstrated (Murante and Gasiewicz, 2000; Sakai et al., 2003; Staples et al., 1998) . This is the most immature population of hematopoietic cells observed to be altered by TCDD treatment. Although predominantly quiescent, HSC are characterized by a robust proliferative capacity and the ability for self-renewal. In addition, these cells are defined by the ability to differentiate into all of the blood lineages by first committing to hematopoietic progenitor cells (HPC) that are themselves committed to either the MOL 21006 6 hematopoiesis, including proliferation and differentiation, are controlled by circadian rhythms. For example, the number of human CD34 + bone marrow cells as well as those in S-phase has been shown to be rhythmic (Abrahamsen et al., 1998) .
Rhythmicity in numbers of erythroid progenitors, BFU-E and CFU-E, and myeloid progenitors, CFU-GEMM and CFU-GM, have been identified (Aardal and Laerum, 1983; Smaaland et al., 1992; Wood et al., 1998) . Although it is likely that at least part of their rhythmicity is regulated by circadian-controlled circulating factors, these cells express all of the machinery required for an intrinsic circadian clock and maintain rhythmicity in vitro (Bourin et al., 2002; Tsinkalovsky et al., 2005) .
The AhR itself has been linked to circadian physiology. Both mRNA and protein levels of AhR in rat liver oscillates in a circadian manner Richardson et al., 1998 ). Not surprising, the level of CYP1A1 mRNA, one of the AhR-regulated genes, has a rhythm that is anti-phase to the AhR. A single acute exposure to TCDD also disrupted circadian-controlled rest/activity rhythms in mice, as well as the rhythms associated with the expression of circadian genes Per1 and BMAL1 in the hypothalamus (Miller, 1999) . The purpose of these experiments was to test the hypothesis that dysregulation of the AhR signaling pathway resulting from exposure to a persistent AhR agonist TCDD could disrupt the circadian rhythms of antigenically-and functionally-defined hematopoietic precursors.
Materials and Methods
This article has not been copyedited and formatted. The final version may differ from this version. Animals. Five-week old female C57Bl/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and allowed to acclimate for a period of one week. All animals were cared for under a protocol approved by the University Committee on Animal Resources. They were provided food and water ad libitum. Lights were maintained on a twelve-on/twelve-off schedule, turning on and off at 6:00 am and 6:00 pm. These times correspond with Zeitgeber times (ZT) 0 and 12, respectively.
TCDD Exposure. Mice were gavaged with 10µg/kg TCDD in 5µL olive oil per 1g mouse weight, or oil alone five days prior to the first timepoint. In all studies, time points consisted of ZT6, 10, 14, 18, 22, and 2. The five day time point was predetermined to be optimal in generating an effect on the percent of quiescent Lin -Sca-1 + cells in the BM; this effect was maximal between days 3 through 7 following exposure (not shown).
Bone Marrow Cell Isolation. Bone marrow cells were flushed from both femurs and tibiae with PBS + 2% FBS + 1% penicillin/streptomycin as previously described (Wyman et al., 2002; Laiosa et al., 2003) . The bone marrow cells were placed in to a single cell suspension before passing through an 80-µm nylon mesh (TETKO Inc., Briarcliff Manor, NY antibodies to Mac-1, Gr-1, CD8a, CD3ε, Ter119, and B220. Streptavidin-PerCP was used a secondary fluorescent agent. Cells were rinsed with staining buffer and fixed with 0.1% paraformaldehyde prior to running on the flow cytometer. As compared to our previous studies (Murante and Gasiewicz, 2000; Staples et al., 1998) , the use of the Thy-1 marker allows further definition of the Lin -Sca-1 + cKit + (LSK) population to include those cells that are phenotypically-and functionally-defined as long-term (LT) and shortterm (ST) HSC. Cells were run (at least 50,000 events per sample) on a FACSCalibur flow cytometer (BD Biosciences) and data were analyzed with CellQuest software (BD Biosciences). Gates were set similarly as previously described (Staples et al., 1998; Murante and Gasiewicz, 2000; Akashi et al., 2000; Kondo et al., 1997) and data were taken as percentages of cells in the viable gates.
Cell Isolation for RNA Analysis. Total BM was harvested from both legs (femur + tibia) and blocked with anti-FcR in stain buffer. The cells were then stained with biotinylated anti-lineage (Mac-1, Gr-1, B220, CD8α, CD3ε, Ter119) followed by 
Results
This article has not been copyedited and formatted. The final version may differ from this version. carried out over the course of about one year. These studies were carried out due to known seasonal variations in these diurnal patterns. Occasionally, these experiments conducted at different seasons also suggested abnormal period and/or phase shifts following exposure toTCDD (data not shown).
Since there is a considerable body of literature demonstrating circadian rhythmicity in myeloid and erythroid precursors (Aardal and Laerum, 1983; Smaaland et al., 1992; Wood et al., 1998) , these studies were extended to examine effects This article has not been copyedited and formatted. The final version may differ from this version. on these populations. CMP, GMP, and MEP all were characterized by apparent rhythms in control animals ( Fig. 2) . Five days following TCDD exposure, the rhythms of all three populations were altered (ANOVA p value < 0.001), demonstrating changes in phase and magnitude that are both time-of-day-and cell-type specific (Fig. 2) . In addition to measuring antigenically-defined hematopoietic precursors, we performed methylcellulose based ex vivo assays to determine effects on functional capacity by measuring high proliferative potential colony-forming cells (HPP-CFC), colony-forming unit granulocyte erythrocyte macrophage megakaryocyte (CFU-GEMM) and CFUgranulocyte macrophage (CFU-GM). As was seen with those antigenically-defined cells, these functionally-defined populations were all characterized by diurnal rhythms (Fig. 3) . Although time-of-day-specific changes may have occurred following TCDD treatment, there were no overall significant treatment-dependent differences when the 24-hour data sets for these colony assays were compared. Together, these data demonstrate that a single oral dose of TCDD is sufficient to cause a modification in the circadian rhythms of murine hematopoietic precursors, as well as overall changes in their numbers. These changes can be both positive and negative, with time points during a daily cycle that are absent of differences between treatment groups.
TCDD disrupts the circadian rhythm of LSK quiescence. Simultaneous staining for RNA and DNA allows discrimination between G 0 and G 1 phase cells. This is an important distinction to make when investigating HSC because of their relatively high representation in quiescence (G 0 ) under normal homeostatic conditions. In addition, G 0 human CD34 + cells, a population enriched for human HSC, were found to be more also suggests the possibility that the period of the rhythm has been compressed.
Together , these data suggest that one possible mechanism by which TCDD-induced AhR activation alters the numbers and rhythms of primitive hematopoietic progenitors is the disruption of their movement in and out of quiescence. These data are also consistent with other studies from our lab showing increased BrdU incorporation into LSK marrow cells following TCDD treatment (manuscript submitted).
TCDD disrupts the circadian rhythm of Lin -Sca-1 + gene expression. Circadian rhythms are controlled by tightly regulated molecular clocks, at the heart of which are several PAS transcription factors, including the murine Period homologues mPer1 and mPer 2, that are structurally similar to the AhR and its dimerization partner Arnt (Zheng et al., 2001) . These proteins act as important positive regulators of the circadian clock.
Very recently, a second putative AhR DNA response element has been identified This article has not been copyedited and formatted. The final version may differ from this version. (Boutros et al., 2004) . We therefore sought to determine whether exposure to TCDD could disrupt the expression of these genes in Lin -Sca-1 + bone marrow cells. The data presented in Figure 5 agree with previous studies demonstrating that mPer1 and mPer2 are expressed in murine marrow Lin -Sca-1 + cells and that this expression is itself circadian in manner (Chen et al., 2000; Tsinkalovsky et al., 2005) . Both mPer1 and mPer2 are characterized by rhythms that have maximal expression near ZT14 and ZT23, respectively. These patterns were disrupted by TCDD treatment (ANOVA p value < 0.05) with peaks being truncated by nearly 50%. The cyclin dependent kinase inhibitors p21 and p27 also have been demonstrated to be both TCDD responsive and regulated with circadian rhythmicity (Bjarnason et al., 1999; Cheng et al., 2000; Enan et al., 1998; Kolluri et al., 1999) .
However, analysis of their mRNA expression over twenty-four hours revealed only modest rhythmicity in Lin -Sca-1 + cells and no changes with TCDD exposure (data not shown). Together, these data support previous findings that hematopoietic precursors express circadian related genes. These data also indicate that this expression is susceptible to dysregulation by TCDD.
Finally, it has been demonstrated by others that both AhR mRNA and protein expression are circadian regulated in several other tissues including rat liver Richardson et al., 1998 occurring during subjective mid-day (near ZT10) with minimal expression occurring during the hours surrounding the transition from dark to light (Fig. 6 ). These curves were not significantly modified following TCDD exposure (data not shown). The AhR repressor (AhRR) is a recently characterized TCDD-inducible member of the AhR signaling pathway that competes with the AhR for binding to both AhRE and Arnt and acts as a negative regulator of AhR-elicited transcriptional activity (Baba et al., 2001) . occurring approximately twelve hours later (Fig. 7) . Together, these data demonstrate that the members of the AhR signaling pathway are expressed in a circadian manner in murine hematopoietic precursors and that the expression of the AhRR is susceptible to TCDD-induced dysregulation.
This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Processes regulating the numbers of hematopoietic stem and progenitor cells are under the control of circadian timing mechanisms (Aardal and Laerum, 1983; Abrahamsen et al., 1998; Smaaland et al., 1992; Wood et al., 1998) . As such, the number of murine hematopoietic progenitors can change as much as 2-to 3-fold during the course of a single day. Although these rhythms demonstrate a change in a specific antigenically-or functionally-defined cell type, it is important to understand that this 3, GM-CSF, and G-CSF was also found to be circadian-dependent (Perpoint et al., 1995) .
We have presented data that for the first time indicate circadian rhythms in the numbers of specific antigenically-defined populations of murine hematopoietic progenitor cells. Hypothetically, a measurable plasticity may exist between erythroid and myeloid progenitors, with a single cell changing surface levels of proteins such as FcR and CD34 so that it meets the criteria for both GMP and MEP at different times of the day.
The anti-phase nature of the curves for those two populations supports this notion (Fig.   2 ). This kind of temporal compartmentalization provides for unique periods of specific timing and duration when cellular and extracellular factors required for a specific differentiation program are likely up-regulated. Properly timed circadian rhythms are hypothesized to be energetically advantageous to the organism, allowing production of signaling molecules and receptors only when they are required. Five days after TCDD exposure there appeared to be a shift in the timing of the GMP and MEP rhythms; although those two specific curves remained anti-phase to one another, adding support to our hypothesis that these are indeed the same cells. Although the absolute minimum numbers of these two populations do not change following TCDD treatment, the This article has not been copyedited and formatted. The final version may differ from this version. In addition to numbers of specific cells, the apparent function and proliferation of HSC and HPC is also temporally dependent. The cell cycle of both primitive hematopoietic progenitors and other cell types progresses with a twenty-four hour period and is linked to the co-expression of circadian associated genes. Notably, the ability of transplanted murine bone marrow to engraft is influenced by circadian time (D'Hondt et al., 2004) .
This article has not been copyedited and formatted. The final version may differ from this version. (Jetmore et al., 2002) . It is therefore not surprising that the rhythm of S-phase HSC and HSC engraftment are anti-phase to each other (D'Hondt et al., 2004) and that the number of colony forming unit-spleen (CFU-S) are measured with a circadian period . We have shown a TCDD-elicited disruption in the quiescence of LSK cells (Fig. 4) . These data are important for several reasons. First, the regulation of HSC division is tightly regulated with the majority (70-85%) of cells quiescent under normal 'resting' conditions; a phenomenon that is critical for the maintenance of hematopoietic potential throughout the lifespan of the organism. Second, this alteration in the functional composition of the bone marrow may explain reported data indicating that TCDD, although increasing their number, diminished the ability of murine LSK/CD34 -cells (functionally defined as longterm reconstituting HSCs) to reconstitute an irradiated recipient mouse (Sakai et al., 2003) . Again, this result may not be surprising if TCDD treatment increases the cycling of HSCs and actively cycling cells are less able to home to bone marrow (Jetmore et al., 2002) .
The proteins mPer1 and mPer2 are important positive arms of the circadian clock.
Targeted mutation of their genes results in abnormal circadian rhythms (Zheng et al., 2001) . However, because the expression of mPer2 normally increases and decreases daily, measuring the effect of TCDD at just one time point can lead to a misinterpretation of the data. When mPer1 and BMAL1 mRNA expression were This article has not been copyedited and formatted. The final version may differ from this version. hours, it was found that the overall rhythm was phase-shifted (Miller et al., 1999) .
Rather than a change in the phase of their rhythms, we observed changes in the magnitude of both mPer1 and mPer2 mRNA in Lin -Sca-1 + BM cells exposed in vivo to TCDD (Fig. 5) . Specifically, their respective maximal expression were reduced by roughly 50%. Although it is unclear what effect this reduction would have on these cells, it is plausible that this transient modulation in mPer mRNA is significant enough to disrupt normal cellular function. In addition, although TCDD has been identified as a tumor promoter, there is currently no data providing a convincing mechanism by which this happens. Notably, mPer mutant mice are more susceptible to γ-irradiation induced tumorogenesis (Fu et al., 2002) . The incidence of lymphoma and tumors in several tissues was nearly 15-fold higher in mPer2 mutant animals, leading to early mortality.
Additionally, a chromosomal translocation fusing ETV6 with the hPer1 gene is associated with acute myeloid leukemia (Penas et al., 2003) . Notably, TCDD exposure to humans has been associated with increased incidence of lymphoma and leukemia (IARC, 1997) . It would be important to further investigate the specific effects of AhRmediated dysregulation of mPer on murine hematopoietic progenitors.
Although we and others have referred to the action of TCDD on the AhR as activation, evidence suggests this may not always be functionally the case. When many types of cells are exposed to TCDD, both in vitro and in vivo, there is a rapid and sustained proteosome-mediated degradation of AhR protein (reviewed in Pollenz, 2002) . In many cases, a single dose of TCDD is sufficient to reduce AhR protein in vivo to 10-30% of This article has not been copyedited and formatted. The final version may differ from this version. control animals in multiple tissues for up to fourteen days (Pollenz et al., 1998) .
However, despite this decrease in the level of AhR, CYP1A1 and/or CYP1B1 increase with TCDD exposure, indicating some continued AhR function or the presence of 'spare' AhR protein. Thus, TCDD may cause a rapid and sustained reduction in AhR protein while directing the remaining active AhR to particular TCDD-inducible genes, including the AhRR (Baba et al., 2001) , adding an additional level of negative regulation. The possible nullification of endogenous AhR activity in HSC/HPC by TCDD is important when considering the following points. First, a putative second AhRE has been identified upstream of the mPer2 gene (Boutros et al., 2004) . Second, we observed a time-of-day-dependent elevated number of LSK cells in AhR-null allele mice (unpublished observations) of a magnitude similar to the increase following TCDD exposure. Third, we observed that TCDD treatment substantially induces AhRR in Lin -Sca-1 + marrow cells (Fig 7) . Thus, a plausible and testable explanation for some of the present data is that TCDD is inducing, either through the ability to elicit down-regulation of AhR protein and/or increased AhRR expression, an AhR-null-like state for signaling pathways regulating HSC/HPC function. Future experiments will investigate the mechanisms by which TCDD may affect distinct AhR functions in murine LSK cells.
In summary, this paper describes a novel effect of AhR activation on immature murine hematopoietic progenitors. Significant changes in the circadian rhythms associated with both the number of antigenically-and functionally-defined cell populations as well as their movement into and out of quiescence were detected. These disruptions include changes in phase, period, and magnitude, and may be related in part to altered ANOVA p values were 0.14, 0.07, and 0.09 for HPP-CPC, CFU-GEMM, and CFU-GM, respectively. 
